These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone. Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316 [No Abstract] [Full Text] [Related]
3. Tamoxifen: an enduring star. Veronesi U; Maisonneuve P; Decensi A J Natl Cancer Inst; 2007 Feb; 99(4):258-60. PubMed ID: 17312297 [No Abstract] [Full Text] [Related]
4. Chemoprevention of breast cancer: recommendations and rationale. Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459 [No Abstract] [Full Text] [Related]
5. Should you be taking tamoxifen? Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):4-5. PubMed ID: 11439691 [No Abstract] [Full Text] [Related]
6. The current status of breast cancer chemoprevention: a star is born. Morrow M; Jordan VC J Surg Oncol; 2007 Jan; 95(1):4-5. PubMed ID: 17192883 [No Abstract] [Full Text] [Related]
7. Tamoxifen and breast cancer prevention: what should you tell your patients? Goel V CMAJ; 1998 Jun; 158(12):1615-7. PubMed ID: 9645176 [No Abstract] [Full Text] [Related]
8. Tamoxifen in cancer therapy: minireview. Novotny L; Rauko P; Vachálková A; Peterson-Biggs M Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680 [TBL] [Abstract][Full Text] [Related]
9. Acceptance of tamoxifen chemoprevention by physicians and women at risk. McKay A; Latosinsky S; Martin W Cancer; 2005 Jan; 103(1):209-10. PubMed ID: 15540238 [No Abstract] [Full Text] [Related]
10. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point. Jordan VC Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908 [No Abstract] [Full Text] [Related]
12. Chemoprevention of breast cancer: a promising idea with an uncertain future. Kinsinger LS; Harris R Lancet; 2002 Sep; 360(9336):813-4. PubMed ID: 12243912 [No Abstract] [Full Text] [Related]
13. [Chemoprevention of breast cancer: a hope justified?]. Buser K; Delaloye JF Rev Med Suisse Romande; 2000 Jun; 120(6):511-3. PubMed ID: 11014095 [TBL] [Abstract][Full Text] [Related]
14. Bilateral swollen eyelids occurring during adjuvant treatment with tamoxifen for early breast cancer. Jaspers H; Blaisse R; Maessen-Visch B; Mattijssen V Neth J Med; 2009 Jun; 67(6):245-6. PubMed ID: 19749398 [No Abstract] [Full Text] [Related]
15. Chemoprevention of breast cancer: recommendations and rationale. Berg AO; Am J Nurs; 2003 May; 103(5):107, 109, 111, 113. PubMed ID: 12759615 [No Abstract] [Full Text] [Related]
16. [Breast cancer chemoprevention. Rational, trials results and future]. Cutuli B; Lesur A; Namer M; Kerbrat P Bull Cancer; 2009 May; 96(5):519-30. PubMed ID: 19467983 [TBL] [Abstract][Full Text] [Related]
18. Tamoxifen for breast cancer prevention. Breckwoldt M; Karck U Exp Clin Endocrinol Diabetes; 2000; 108(4):243-6. PubMed ID: 10961352 [TBL] [Abstract][Full Text] [Related]
19. Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors. Singh Ranger G J Clin Pharm Ther; 2005 Aug; 30(4):313-7. PubMed ID: 15985044 [TBL] [Abstract][Full Text] [Related]
20. The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer. Kelminski A Hawaii Med J; 2002 Sep; 61(9):209-10. PubMed ID: 12422387 [No Abstract] [Full Text] [Related] [Next] [New Search]